Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity von Nowak, Albina, Dormond, Olivier, Monzambani, Véronique, Huynh-Do, Uyen, Barbey, Frédéric

Volltext

Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines von Alcaraz-Serna, Ana, Noto, Alessandra, Ermellino, Laura, Monzambani-Banderet, Véronique, Tommasini, Francesco, Stehlin, Florian, Girard, Cedric, Perreau, Matthieu, Muller, Yannick D.

Volltext

Graded-dosing immunization in adults at risk for immediate-type reactions to mRNA SARS-CoV-2 vaccines von Stehlin, Florian, Tommasini, Francesco, Monzambani-Banderet, Véronique, Girard, Cedric, Yerly, Daniel, Ribi, Camillo, Muller, Yannick D.

Volltext

Intradermal Testing With COVID-19 mRNA Vaccines Predicts Tolerance von Stehlin, Florian, Mahdi-Aljedani, Rima, Canton, Loris, Monzambani-Banderet, Véronique, Miauton, Alix, Girard, Cedric, Kammermann, Kevin, Meylan, Sylvain, Ribi, Camillo, Harr, Thomas, Yerly, Daniel, Muller, Yannick D

Volltext

Agalsidase-β should be proposed as first line therapy in classic male Fabry patients with undetectable α-galactosidase A activity von Nowak, Albina, Dormond, Olivier, Monzambani, Véronique, Huynh-Do, Uyen, Barbey, Frédéric

Volltext

Hypertrophie ventriculaire gauche isolée : et si c’était une maladie de Fabry ? von Barbey, Frédéric, Dormond, Olivier, Monzambani, Véronique, Barbey, Guillaume, Namdar, Mehdi, Monney, Pierre

Volltext

Isolated left ventricular hypertrophy : is it a Fabry disease? von Barbey, Frédéric, Dormond, Olivier, Monzambani, Véronique, Barbey, Guillaume, Namdar, Mehdi, Monney, Pierre

Volltext

Basophil activation tests with cryopreserved mRNA-based COVID-19 vaccines von Ana Alcaraz-Sernaa, Alessandra Notoa, Laura Ermellinoa, Veronique Monzambani-Bandereta, Francesco Tommasinia, Florian Stehlina, Cedric Girardb, Matthieu Perreaua, Yannick D. Mullera

Volltext